STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma
Clinical trial NCT01551693 · TERMINATED
Trial details
- NCT number
- NCT01551693
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-09-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.